Montreal Heart Institute

Montreal Heart Institute

OMEICOS Therapeutics is working closely together with the research group of Dr. Stanley Nattel to investigate the anti-arrhythmic effect of OMEICOS’ compounds in atrial fibrillation. Dr. Nattel’s lab is one of the world’s leading research teams focused on clinically-relevant mechanisms of atrial fibrillation, cardiac remodeling, ion channel molecular physiology and mechanisms of drug action.